Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iridex (IRIX) Total Non-Current Liabilities (2016 - 2026)

Iridex has reported Total Non-Current Liabilities over the past 16 years, most recently at $23.8 million for Q1 2026.

  • For Q1 2026, Total Non-Current Liabilities fell 10.78% year-over-year to $23.8 million; the TTM value through Jan 2026 reached $23.8 million, down 10.78%, while the annual FY2026 figure was $23.8 million, 10.78% down from the prior year.
  • Total Non-Current Liabilities for Q1 2026 was $23.8 million at Iridex, up from $23.4 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $27.3 million in Q1 2024 and troughed at $22.7 million in Q3 2023.
  • A 5-year average of $25.5 million and a median of $25.4 million in 2022 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 139.7% in 2022 and later fell 15.3% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $25.0 million in 2022, then decreased by 0.81% to $24.8 million in 2023, then increased by 7.98% to $26.7 million in 2024, then fell by 12.6% to $23.4 million in 2025, then rose by 2.08% to $23.8 million in 2026.
  • Business Quant data shows Total Non-Current Liabilities for IRIX at $23.8 million in Q1 2026, $23.4 million in Q3 2025, and $25.2 million in Q2 2025.